Advaxis, Inc.
The Technology Centre of New Jersey
675 U.S. Route One, South
North Brunswick
New Jersey
08902
United States
Tel: 732-545-1590
Fax: 732-545-1084
Website: http://www.advaxis.com/
About Advaxis, Inc.
Advaxis is a clinical-stage biotechnology company developing cancer immunotherapies that enlist the body’s own immune system to fight cancer.YEAR FOUNDED:
2002
LEADERSHIP:
CEO: Daniel O’Connor
CFO: Sara Bonstein
CSO (Scientific): Robert Petit
JOBS:
Please click here for Advaxis job opportunities.
CLINICAL TRIAL:
Please click here for clinical trial information.
FOLLOW ADVAXIS:
Tweets by Advaxis
539 articles about Advaxis, Inc.
-
Advaxis, Inc. Completes Dosing Vanguard Group in Phase II Cervical Dysplasia (CIN) Study
8/18/2010
-
Advaxis, Inc. Signs Veterinary Study Contract with the University of Pennsylvania School of Veterinary Medicine
8/17/2010
-
Advaxis, Inc. to Present at the 12th Annual 2010 Rodman & Renshaw Healthcare Conference
8/12/2010
-
Advaxis, Inc. and Vibalogics to Co-Develop Stable Storage Formulation for Live Vaccines
8/9/2010
-
Advaxis, Inc. Gets Formal Go-Ahead from India's DCGI to Conduct Phase II Cervical Cancer Trial
8/3/2010
-
Advaxis, Inc. Secures $7.5 Million Financing Commitment
7/20/2010
-
Advaxis, Inc. Hires Accomplished Young Scientist
7/12/2010
-
Advaxis, Inc. and Homeland Security Sign Agreement
6/30/2010
-
Advaxis, Inc. Completes Dosing of Vanguard Patient Group in Phase II Cervical Dysplasia Clinical Trial
6/23/2010
-
Advaxis, Inc. Annual Meeting Recap
6/3/2010
-
Advaxis, Inc. and Department of Homeland Security Agree to Cooperative Research and Development Agreement
6/2/2010
-
Advaxis, Inc. Doses First Cervical Dysplasia Clinical Trial Patient
5/28/2010
-
Advaxis, Inc. to Present at the Noble Financial Sixth Annual Equity Conference – ONTRACK 2010
5/25/2010
-
Advaxis, Inc. Invites Shareholders to the 2010 Advaxis Annual General Meeting
5/25/2010
-
Advaxis, Inc. and the University of Pennsylvania Reach Agreement
5/18/2010
-
Advaxis, Inc. Chairman/CEO Thomas A. Moore Presents at the BIO International Convention in Chicago, IL
5/5/2010
-
Advaxis, Inc. to Host Investigators Meeting for ADXS11-001 Cervix Cancer Trial in Mumbai, India
5/3/2010
-
Advaxis, Inc.'s Live Listeria Prostate Cancer Vaccine Heads for Clinic
4/30/2010
-
Advaxis, Inc. Initiates Phase II Cervical Dysplasia (CIN) Trial
4/15/2010
-
Advaxis, Inc. to Present at the 6th Annual Spring Growth Stock Conference
3/25/2010